X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Elder Pharma with ASTRAZENECA PHARMA - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ELDER PHARMA vs ASTRAZENECA PHARMA - Comparison Results

ASTRAZENECA PHARMA 
   Change

AstraZeneca Pharma India Limited (APIL) is a 90% subsidiary of the UK based AstraZeneca Pharmaceuticals, which is one of the world's leading pharma companies. APIL has interests in the six crucial areas of cardiovascular, respiratory, maternal health... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ELDER PHARMA ASTRAZENECA PHARMA ELDER PHARMA/
ASTRAZENECA PHARMA
 
P/E (TTM) x -0.2 91.5 - View Chart
P/BV x 0.1 13.0 0.8% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 ELDER PHARMA   ASTRAZENECA PHARMA
EQUITY SHARE DATA
    ELDER PHARMA
Jun-14
ASTRAZENECA PHARMA
Mar-14
ELDER PHARMA/
ASTRAZENECA PHARMA
5-Yr Chart
Click to enlarge
High Rs3801,285 29.6%   
Low Rs188634 29.7%   
Sales per share (Unadj.) Rs491.2189.6 259.1%  
Earnings per share (Unadj.) Rs-3.2-0.2 1,562.7%  
Cash flow per share (Unadj.) Rs14.43.8 374.8%  
Dividends per share (Unadj.) Rs00-  
Dividend yield (eoy) %00-  
Book value per share (Unadj.) Rs376.568.6 548.5%  
Shares outstanding (eoy) m20.5425.00 82.2%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.65.1 11.4%   
Avg P/E ratio x-89.3-4,712.7 1.9%  
P/CF ratio (eoy) x19.7249.6 7.9%  
Price / Book Value ratio x0.814.0 5.4%  
Dividend payout %00-   
Avg Mkt Cap Rs m5,83323,988 24.3%   
No. of employees `000NA1.6 0.0%   
Total wages/salary Rs m2,1791,605 135.8%   
Avg. sales/employee Rs ThNM3,040.2-  
Avg. wages/employee Rs ThNM1,029.2-  
Avg. net profit/employee Rs ThNM-3.3-  
INCOME DATA
Net Sales Rs m10,0894,740 212.9%  
Other income Rs m25792 278.6%   
Total revenues Rs m10,3464,832 214.1%   
Gross profit Rs m-792-130 610.1%  
Depreciation Rs m361101 357.0%   
Interest Rs m2,7560-   
Profit before tax Rs m-3,653-139 2,629.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m3,713139 2,672.9%   
Tax Rs m1255 2,458.7%   
Profit after tax Rs m-65-5 1,283.9%  
Gross profit margin %-7.8-2.7 286.6%  
Effective tax rate %-3.4-3.7 93.5%   
Net profit margin %-0.6-0.1 603.2%  
BALANCE SHEET DATA
Current assets Rs m9,2402,726 338.9%   
Current liabilities Rs m9,9982,435 410.6%   
Net working cap to sales %-7.56.1 -122.2%  
Current ratio x0.91.1 82.5%  
Inventory Days Days4674 62.8%  
Debtors Days Days6041 147.1%  
Net fixed assets Rs m10,1241,035 977.9%   
Share capital Rs m20650 411.4%   
"Free" reserves Rs m5,582942 592.3%   
Net worth Rs m7,7341,716 450.7%   
Long term debt Rs m4,8890-   
Total assets Rs m22,8824,156 550.6%  
Interest coverage x-0.3NM-  
Debt to equity ratio x0.60-  
Sales to assets ratio x0.41.1 38.7%   
Return on assets %11.8-0.1 -9,602.2%  
Return on equity %-0.8-0.3 284.9%  
Return on capital %22.30-  
Exports to sales %3.05.7 53.3%   
Imports to sales %0.46.5 6.6%   
Exports (fob) Rs m307270 113.5%   
Imports (cif) Rs m43306 14.1%   
Fx inflow Rs m307375 81.8%   
Fx outflow Rs m125470 26.7%   
Net fx Rs m181-96 -189.7%   
CASH FLOW
From Operations Rs m11,754-8 -145,112.3%  
From Investments Rs m-561-146 384.7%  
From Financial Activity Rs m-6,762862 -784.2%  
Net Cashflow Rs m4,432709 625.5%  

Share Holding

Indian Promoters % 39.6 0.0 -  
Foreign collaborators % 0.0 75.0 -  
Indian inst/Mut Fund % 7.5 0.3 2,500.0%  
FIIs % 16.8 15.7 107.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 36.1 9.1 396.7%  
Shareholders   16,479 12,856 128.2%  
Pledged promoter(s) holding % 77.6 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ELDER PHARMA With:   STERLING BIOTECH  PFIZER  ALEMBIC PHARMA  ORCHID PHARMA LTD  SANOFI INDIA  

Compare ELDER PHARMA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices Continue Momentum; Realty Sector Up 2.7%(11:30 am)

After opening the day higher, stock markets in India have continued their momentum. Sectoral indices are trading on a positive note with stocks in the realty sector.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

This Small Cap Can Drive Chinese Players Out of India (and Make a Fortune in the Process)(The 5 Minute Wrapup)

Aug 17, 2017

A small-cap Indian company with high-return potential and blue-chip-like stability is set to supplant the Chinese players in this niche segment.

The Most Important Innovation in Finance Since Gold Coins(Vivek Kaul's Diary)

Aug 10, 2017

Bill connects the dots...between money and growth, real money and real resources, gold and cryptocurrencies...and between gold, cryptocurrencies, and time.

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ELDER PHARMA SHARE PRICE


Sep 12, 2016 (Close)

TRACK ELDER PHARMA

  • Track your investment in ELDER PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ELDER PHARMA 5-YR ANALYSIS

COMPARE ELDER PHARMA WITH

MARKET STATS